T1	Participants 21 82	vitamin E supplementation on cardiovascular events and cancer
T2	Participants 183 246	E supplementation may prevent cancer and cardiovascular events.
T3	Participants 365 501	To evaluate whether long-term supplementation with vitamin E decreases the risk of cancer, cancer death, and major cardiovascular events
T4	Participants 533 890	A randomized, double-blind, placebo-controlled international trial (the initial Heart Outcomes Prevention Evaluation [HOPE] trial conducted between December 21, 1993, and April 15, 1999) of patients at least 55 years old with vascular disease or diabetes mellitus was extended (HOPE-The Ongoing Outcomes [HOPE-TOO]) between April 16, 1999, and May 26, 2003.
T5	Participants 906 1002	267 HOPE centers that had enrolled 9541 patients, 174 centers participated in the HOPE-TOO trial
T6	Participants 1007 1212	7030 patients enrolled at these centers, 916 were deceased at the beginning of the extension, 1382 refused participation, 3994 continued to take the study intervention, and 738 agreed to passive follow-up.
